To the Editor The article by Hood et al1 states that aspirin offers protection from postoperative venous thromboembolism following total knee arthroplasty that is not inferior to the protection provided by anticoagulants. To achieve efficacy, vitamin K antagonists are given according to the international normalized ratio value, while direct anticoagulants are usually given in fixed dosages. On the other hand, aspirin efficacy is more variable and is difficult to assess in the normal clinical routine. Enteric-coated vs non–enteric-coated tablets, differences in doses, and the influence of body weight all combine to affect the results,2,3 in addition to the unpredictable nonadherence of the patients.4 For these reasons, we would like to know more details of the kind of pharmaceutical formulation and dosages of aspirin that were used in the study by Hood et al.1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Gnecchi-Ruscone T, Restifo Pecorella D. Which Aspirin to Choose? JAMA Surg. 2019;154(6):565. doi:10.1001/jamasurg.2019.0112
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: